As a “By Invitation
only” event, invitations are only extended to those
companies operating in the human therapeutic drug discovery:
The CEO, President or
Member of the Board from early stage Biopharmaceutical
Companies focused on therapeutic drug development.
Senior Executives, such as Director
or EVP, with responsibility for R&D, Licensing, M&A
and Business Development from Major
Pharmaceutical and Major Biotech Companies
Invitations are not extended to:
Service
providers such as CRO's, technology platform, data support
or consultancy companies
Banks, law firms, VC or funding companies
Journalists and representatives from
the media
The rationale for this conference is for
like minded, senior executives to explore new business opportunities
in a relaxed and informal atmosphere, away from the every day
distractions of the office. As the conference program does not
allow for advertorial presentations, nor are there any companies
exhibiting, you only need to enter into discussions with those
executives with whom you really want to do business.
The conference is funded by private sponsorships
and delegate registration fees and not exhibitor places. This
formula has succeeded in retaining this event’s quality
& reputation as one of the most exclusive in the Biotech
conference calendar.
